Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2016 049 931.2 |
96 | EP file number | EAKZ | 16 78 0526.6 |
86 | WO file number | WAKZ | PCT/US2016/027014 |
97 | EP publication number | EPN | 3283882 |
87 | WO publication number | WPN | 2016168133 |
54 | Designation/title | TI | BLUTBASIERTE BIOMARKER DER TUMOREMPFINDLICHKEIT GEGEN PD-1-ANTAGONISTEN |
51 | IPC main class | ICM (ICMV) | G01N 33/543 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | G01N 33/566 (2006.01), G01N 33/574 (2006.01), G01N 33/68 (2006.01) |
22 | DE application date | DAT | Apr 12, 2016 |
96 | EP application date | EAT | Apr 12, 2016 |
86 | WO application date | WAT | Apr 12, 2016 |
43 | Date of first publication | OT | Oct 20, 2016 |
| Date of publication of grant | PET | Dec 16, 2020 |
71/73 | Applicant/owner | INH | Merck Sharp & Dohme LLC, Rahway, NJ, US |
72 | Inventor | IN | AYERS, Mark, West Point, Pennsylvania 19486, US; LUNCEFORD, Jared, Washington, Utah 84780, US; LOBODA, Andrey, Boston, Massachusetts 02115-5727, US; NEBOZHYN, Michael, West Point, Pennsylvania 19486, US; MCCLANAHAN, Terrill, K., Palo Alto, California 94304, US; HIRSCH, Heather, Brookline, Massachusetts 02445, US |
74 | Representative | VTR | Abitz & Partner Patentanwälte mbB, 81925 München, DE |
| Address for service | | Abitz & Partner Patentanwälte mbB, 81628 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201562149333 P Apr 17, 2015
|
| Due date | FT FG | Apr 30, 2026 Annual fee for the 11th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003283882A1 Searchable text:
EP000003283882A1 Original document:
EP000003283882B1 Searchable text:
EP000003283882B1 Original document:
EP000003283882B2 Searchable text:
EP000003283882B2 Original document:
WO002016168133 Searchable text:
WO002016168133 |
43 | Date of first publication | EVT | Oct 20, 2016 |
| Date of the first transfer into DPMAregister | EREGT | Feb 21, 2018 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 22, 2025 (Show all update days)(Hide all update days)- Mar 22, 2025
- Oct 31, 2024
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 16.10.2024: changed
- Sep 26, 2024
- Published EP/WO documents: changed
- Procedures: Opposition procedure, Decision by EPO to maintain patent in amended form has become final, 16.10.2024: new
- Procedures: Opposition procedure, Patent maintained in amended form by EPO, 16.10.2024: new
- Jul 20, 2024
- St.36: changed (technical change)
- Jun 27, 2024; May 8, 2024; Mar 21, 2024; Mar 24, 2023; Nov 10, 2022; Sep 30, 2022; Mar 24, 2022; Oct 21, 2021; Oct 7, 2021; Jul 22, 2021; Mar 9, 2021; Mar 5, 2021; Dec 24, 2020; Dec 2, 2020; Nov 26, 2020; Dec 19, 2019
- Historical data not available for this/these date(s)
- Feb 21, 2018
- Date of the first transfer into DPMAregister
|